SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurochem (NRMX)
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
54 10 0 NRMX
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
29forbes: Neurochem CEO: Odds Of Kiacta Approval 'Much Higher' Peter Kang,mopgcw-8/15/2006
28Message 22719104mopgcw-8/15/2006
27Neurochem announces award denying majority of Immtech`s claims June 12, 2006 0LJM-6/12/2006
26Neurochem reports results for first quarter of fiscal 2006 Tuesday May 9, 6:07 pmopgcw-5/12/2006
25Neurochem announces eprodisate (Fibrillex(TM)) NDA filed and granted priority remopgcw-4/18/2006
24I love analysts, RBC just upgraded NRMX and raised their price target to $C12 frschzammm-2/7/2006
23Message 21909102mopgcw-11/23/2005
22Neurochem receives third positive recommendation from Independent Safety Review mopgcw-10/5/2005
21Neurochem initiates submission of NDA with the U.S. FDA for Fibrillex(TM) in AA mopgcw-8/23/2005
20>>ECUBLENS, Switzerland, June 30 /PRNewswire-FirstCall/ - Neurochem (Intertuck-6/30/2005
19Neurochem receives second positive recommendation from independent safety reviewmopgcw-6/14/2005
18New Fibrillex(TM) Data Presented at the European Renal Association-European Dialmopgcw-6/7/2005
17At Annual and Special Meeting of Shareholders - Neurochem highlights the advancemopgcw-5/16/2005
16Neurochem receives positive recommendation from Independent Safety Review Board mopgcw-4/27/2005
15Neurochem announces preliminary results of phase II/III clinical study for Fibrimopgcw-4/25/2005
14UPDATE 3-Neurochem plunges on disappointing study results Mon Apr 18, 2005 12:56mopgcw-4/25/2005
13Message 21209845mopgcw-4/8/2005
12Pubs: Chakfe, Y., R. Seguin, J.P. Antel, C. Morissette, D. Malo, D. Henderson, mopgcw-2/24/2005
11Neurochem Inc. announces the signing of exclusive collaboration and distributionmopgcw-2/24/2005
10Francesco Bellini renews mandate for three-years as chairman, president and CEO mopgcw-2/24/2005
9Investing in a Cure By Charly Travers (TMFBreakerCharly) February 8, 2005 Alzmopgcw-2/24/2005
8Neurochem reports results for fourth quarter and fiscal year 2004 Tuesday Februmopgcw-2/24/2005
7Neurochem Files Preliminary Prospectus For Sale Of 4M Shrs DOW JONES NEWSWIRES mopgcw-2/24/2005
6Neurochem/Centocor Pact Includes Letter Of Credit By ANDY GEORGIADES February 1mopgcw-2/18/2005
5Francesco Bellini Renews Mandate For Three-years As Chairman, President And CEO mopgcw-1/21/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News